Bone Turnover
Showing 1 - 25 of >10,000
Intestinal Failure, Osteoporosis, Insulin Sensitivity Trial (Parenteral nutrition)
Not yet recruiting
- Intestinal Failure
- +2 more
- Parenteral nutrition
- (no location specified)
May 11, 2023
Type 2 Diabetes, Osteopenia Trial in Odense (oral Semaglutide/Rybelsus, Placebo)
Not yet recruiting
- Type 2 Diabetes
- Osteopenia
- oral Semaglutide/Rybelsus
- Placebo
-
Odense, DenmarkOdense University Hospital
Sep 21, 2023
Bone Turnover in Childern and Adolescents With Type 1 Diabetes
Not yet recruiting
- Type 1 Diabetes
- serum ostecalcin,serum sclerostin and parathroid profile
-
Sohag, EgyptSohag university Hospital
May 29, 2023
Bone Turnover in Type 2 Diabetes and Non-diabetes Controls
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Bone Fragile
- None - crossectional
-
Aarhus N, DenmarkAarhus University Hospital
Oct 14, 2022
Bone Markers in Pediatric IF
Recruiting
- Intestinal Failure
- +2 more
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Jun 9, 2023
Osteoporosis Risk, Menopause Trial in Amsterdam (Estradiol patch, Progesterone)
Not yet recruiting
- Osteoporosis Risk
- Menopause
- Estradiol patch
- Progesterone
-
Amsterdam, NetherlandsAmsterdam UMC
Jun 12, 2023
Precision Medicine Approaches to Renal Osteodystrophy
Recruiting
- Renal Osteodystrophy
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
May 28, 2023
Osteopenia or Osteoporosis Trial in Aarhus C (Conventional alendronate, Effervescent and buffered alendronate)
Active, not recruiting
- Osteopenia or Osteoporosis
- Conventional alendronate
- Effervescent and buffered alendronate
-
Aarhus C, Central Denmark Region, DenmarkAarhus University Hospital
Apr 12, 2022
Effects of Lansoprazole on Bone Turnover Markers
Completed
- Bone Turnover Rate Disorder
- Calcium Metabolism Disorders
- Blood and urine specimens
-
Erzurum, TurkeyAtaturk University Hospital
Jan 10, 2022
Calcium, Osteopenia, Bone Mineral Density Trial in Taipei (amorphous calcium carbonate/ Placebo)
Completed
- Calcium
- +3 more
- amorphous calcium carbonate/ Placebo
-
Taipei, TaiwanTaipei Medical University
Apr 11, 2023
Osteoporosis Trial in Komagane (Ibandronic acid, vitamin D)
Recruiting
- Osteoporosis
- Ibandronic acid, vitamin D
-
Komagane, Nagano, JapanShowa Inan General Hospital
Sep 20, 2021
Other Disorders of Bone Development and Growth Trial in University Park (Combined Oral Contraceptive (COC), Contraceptive
Active, not recruiting
- Other Disorders of Bone Development and Growth
- Combined Oral Contraceptive (COC)
- Contraceptive Vaginal Ring (CVR)
-
University Park, PennsylvaniaWomen's Health and Exercise Laboratories, The Pennsylvania State
Mar 31, 2022
Nutritional Rickets, Bone Turnover Rate Disorder Trial in Cairo (Vit C)
Enrolling by invitation
- Nutritional Rickets
- Bone Turnover Rate Disorder
- Vit C
-
Cairo, EgyptCairo University Faculty of Medicine ,Abo elrish Hospital
Mar 26, 2022
Osteoporosis, Postmenopausal Trial in Kennesaw (Quercetin (500 mg), Placebo (500 mg))
Completed
- Osteoporosis, Postmenopausal
- Quercetin (500 mg)
- Placebo (500 mg)
-
Kennesaw, GeorgiaKennesaw State University
May 7, 2022
Acute Lymphoblastic Leukemia, Vitamin d Deficiency Trial in Mexico City (?-3 polyunsaturated fatty acids (DHA and EPA), Vitamin
Recruiting
- Acute Lymphoblastic Leukemia
- Vitamin d Deficiency
- ω-3 polyunsaturated fatty acids (DHA and EPA), Vitamin D (cholecalciferol), Calcium (calcium carbonate)
-
Mexico City, MexicoUnit of research in Nutrition, Pediatric Hospital, Instituto Mex
Jul 10, 2023
Multiple Myeloma Treated With Intravenous Bisphosphonate in
Recruiting
- Multiple Myeloma
- Blood and urine collection
-
Paris, FranceNecker Hospital, Adult haematology department
Oct 1, 2021
Osteoporosis Trial (PMA-zeolite)
Completed
- Osteoporosis
- PMA-zeolite
- (no location specified)
Dec 16, 2021
Bariatric Surgery Candidate, Bone Loss Trial in San Francisco, Boston (Denosumab, Placebo, Zoledronic Acid)
Recruiting
- Bariatric Surgery Candidate
- Bone Loss
- Denosumab
- +2 more
-
San Francisco, California
- +1 more
Apr 4, 2022
Osteopenia Trial in Odense (Ozempic, Placebo)
Recruiting
- Osteopenia
- Ozempic
- Placebo
-
Odense, Region Of Southern Denmark, DenmarkOdense University Hospital
Mar 26, 2021
Bone Turnover Markers During Discontinuation With Alendronate
Completed
- Osteoporosis
- Discontinue alendronate
-
Aarhus, DenmarkDepartment of Endocrinology and Internal Medicine, Aarhus Univer
Mar 16, 2021
Atopic Dermatitis, Atopic Eczema Trial in Hellerup (Betnovate, betamethasone dipropionate ointment 0.1% and , Protopic,
Completed
- Atopic Dermatitis
- Atopic Eczema
- Betnovate, betamethasone dipropionate ointment 0.1% and placebo
- Protopic, tacrolimus ointment 0.1%
-
Hellerup, Region Hovedstaden, DenmarkDepartment of Dermatology and Allergy
Apr 27, 2021
Bone Metabolism and Turnover in Hospitalized Patients
Recruiting
- Hyponatremia
- blood sampling
-
Basel, SwitzerlandEndocrinology, Diabetes and Metabolism, University Hospital Base
Nov 24, 2021
Effect of Fatty Liver Disease on Bone Density
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Osteoporosis
- (no location specified)
Apr 18, 2021
Healthy, Females, Bone Trial in Toronto (Resistance and Plyometric Exercise, Carbohydrate (Maltodextrin powder mixed with
Terminated
- Healthy
- +3 more
- Resistance and Plyometric Exercise
- +2 more
-
Toronto, Ontario, CanadaYork University
May 13, 2021
Erosive Osteoarthritis Trial in Ghent (Alendronate Effervescent Oral Tablet)
Recruiting
- Erosive Osteoarthritis
- Alendronate Effervescent Oral Tablet
-
Ghent, BelgiumGhent University Hospital
Nov 3, 2020